Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. (Q44836524)
Jump to navigation
Jump to search
scientific article published on 8 April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. |
scientific article published on 8 April 2004 |
Statements
1 reference
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. (English)
1 reference
Sergio Giralt
1 reference
Elizabeth J Shpall
1 reference
Richard E Champlin
1 reference
Peter F Thall
1 reference
Martin Korbling
1 reference
Munir Shahjahan
1 reference
Betty Pierre
1 reference
Roy Jones
1 reference
Marcos de Lima
1 reference
Daniel Couriel
1 reference
Xuemei Wang
1 reference
Timothy Madden
1 reference
James A Russell
1 reference
Borje S Andersson
1 reference
8 April 2004
1 reference
Identifiers
1 reference